desk
Share
News Topical, Digital Desk : Shares of pharma company Wockhardt rose more than 8% to a peak of Rs 1,867.90 per share on Wednesday, June 18. In the last one month, the shares of this pharma company have seen a spectacular rise of about 45%. This rise in the shares came due to heavy trading volume and increasing interest of investors. On June 18, more than 35 lakh shares were traded in the first three hours, worth about Rs 640 crore. This is more than the 10-day average volume of the stock.
On June 12, Wockhardt shares hit a 52-week high of Rs 1,868.80. After this, the shares fell marginally in a few sessions, but on June 18, a strong jump was seen again.
Focus on Zaynich drug Investors are eyeing Wockhardt's new drug Zyanich. It is claimed to be a great antibiotic against drug-resistant infections. Earlier this month, the company's management said that they plan to file a new drug application (NDA) for Zaynich with the US drug regulator in the second quarter of the current financial year. How have been the company's March quarter results? Wockhardt's net loss narrowed to Rs 45 crore in the fourth quarter of FY 2025, from Rs 177 crore last year. Income grew by 6% and increased from Rs 700 crore to Rs 743 crore. The company's EBITDA was Rs 64 crore, which was positive in contrast to the loss of Rs 103 crore in the fourth quarter of last year.
Read More: Stocks to Buy: These stocks are expected to rise up to 40%, investment advice received this week
--Advertisement--
